DERM
Journey Medical Corp.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$7.31
−0.68%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- $0.02
- Revenue estimate
- $21.9M
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.01
- EPS estimate
- -$0.02
- Revenue actual
- $18.5M
- Revenue estimate
- $18.4M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 8
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +15.5%
- Revenue beats (12Q)
- 4
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$0.02 | -$0.01 | Beat 55.56% | $18.5M |
| May 13, 2026 | -$0.07 | -$0.08 | Miss -14.29% | $16.0M |
| Mar 25, 2026 | -$0.06 | -$0.04 | Beat 33.33% | $16.1M |
| Nov 12, 2025 | -$0.08 | -$0.09 | Miss -12.50% | $17.6M |
| Aug 12, 2025 | -$0.07 | -$0.16 | Miss -128.57% | $15.0M |
| May 14, 2025 | -$0.24 | -$0.18 | Beat 25.00% | $13.1M |
| Mar 26, 2025 | -$0.22 | $0.08 | Beat 136.36% | $13.6M |
| Mar 21, 2024 | -$0.08 | -$0.12 | Miss -50.00% | $15.3M |
| May 22, 2023 | -$0.44 | -$0.57 | Miss -29.55% | $12.2M |
| Nov 10, 2022 | -$0.34 | -$0.57 | Miss -67.65% | $16.1M |
| Mar 23, 2022 | -$0.29 | -$1.64 | Miss -465.52% | $17.5M |
| Dec 10, 2021 | -$0.87 | -$1.16 | Miss -33.57% | $19.6M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026